Skip to main content

Working together to improve the outcome for patients with rare, life-threatening, inherited disorders of the immune system.

Hero

You Can Help

See opportunities to participate in research and help further innovations in care for patients like you.

Find a Study Learn About Our Foundation

Learn About Newborn Screening

Infants with SCID who are transplanted before 3 months of age fare better than infants who are transplanted later in life. Learn more about newborn screenings for SCID and help improve outcomes for this rare disorder in the future.

Learn More

NIH Announces Funding to Establish and Strengthen Rare Disease Research Groups

The National Institutes of Health (NIH) has awarded approximately $26 million in grants in the fiscal year 2025 to begin the fifth cycle of funding for the Rare Diseases Clinical Research Network (RDCRN).

Honeycomb-style infographic showing the structure of the Rare Diseases Clinical Research Network with consortia names
Image
Logos for the Primary Immune Deficiency Treatment Consortium, CGD Association of America, and University of Pittsburgh.

PIDTC/IEWP STAT1 GOF HSCT STUDY - Now open!

On behalf of the PIDTC 6906 Project Working Team and in collaboration with the IEWP, we are collecting data to assess the outcomes of patients with STAT1 Gain of Function of any age who have undergone hematopoietic cell transplantation since 2010, including survivors and non-survivors with any length of follow-up.

Image
Primary Immune Deficiency Treatment Consortium logo

PIDTC Updates

Newsletter of the Primary Immune Deficiency Treatment Consortium

Issue 23 | Summer

Learn More
Newsletter Image